<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[federal government Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/federal+government.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to federal government]]></description>
	<s:counts start="0" returned="20" found="740" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Consumers May Be Told of Identity Theft]]></title>
		<link><![CDATA[http://www.bnet.com/2407-13071_23-372769.html]]></link>
		<description><![CDATA[ Australian businesses may soon be forced to tell their customers if their personal details have been stolen, under proposed new laws to combat identity theft.One of the world's biggest technology security companies, Symantec Corp, says it has been approached to assist the federal government with "advice and support" in...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Fri, 11 Dec 2009 16:17:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/symantec+corp..html"><![CDATA[Symantec Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/australia.html"><![CDATA[Australia]]></category>
		<category domain="http://resources.bnet.com/topic/identity+theft.html"><![CDATA[Identity Theft]]></category>
		<category domain="http://resources.bnet.com/topic/disclosure+law.html"><![CDATA[Disclosure Law]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[Security]]></category>
		<category domain="http://resources.bnet.com/topic/aap.html"><![CDATA[AAP]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SYMC</category>
		<category domain="tickers">SYMC</category>
	</item>
	<item>
		<title><![CDATA[FDA Dislikes Canadian Drugs; Is OK With Chinese Drugs]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005764/fda-dislikes-canadian-drugs-is-ok-with-chinese-drugs/]]></link>
		<description><![CDATA[FDA Commissioner Margaret Hamburg said that allowing reimportation of drugs from Canada raised significant safety questions, in a letter to to Republican Sen. Sam Brownback of Kansas, according to the Wall Street Journal. The story notes that the drug industry lobby group PhRMA also opposes reimportation and has been fighting...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 10 Dec 2009 08:37:39 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[How Gloucester Achieved the Impossible Even Before Inking the Celgene Deal]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005759/how-gloucester-achieved-the-impossible-even-before-inking-the-celgene-deal/]]></link>
		<description><![CDATA[Even before inking a $640 million acquisition by Celgene CELG earlier this week, Gloucester Pharmaceuticals managed to get an FDA approval without tapping the public markets or a partner. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 09 Dec 2009 21:24:17 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/celgene+corp..html"><![CDATA[Celgene Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/mergers+%2526+acquisitions.html"><![CDATA[Mergers & Acquisitions]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+law.html"><![CDATA[Corporate Law]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CELG</category>
		<category domain="tickers">CELG</category>
	</item>
	<item>
		<title><![CDATA[Welfare Groups Buy ABC Learning Centres]]></title>
		<link><![CDATA[http://www.bnet.com/2407-13071_23-371752.html]]></link>
		<description><![CDATA[ The receiver of ABC Learning says the collapsed firm's remaining childcare centres are set to be sold to a syndicate comprising not-for-profit welfare groups.Receiver Chris Honey on Wednesday named the GoodStart syndicate as the preferred purchaser after a bidding process.The syndicate includes Mission Australia, the Benevolent Society, Social Ventures...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Wed, 09 Dec 2009 13:41:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/abc+inc..html"><![CDATA[ABC Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/syndicate.html"><![CDATA[Syndicate]]></category>
		<category domain="http://resources.bnet.com/topic/centre.html"><![CDATA[Centre]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/team+management.html"><![CDATA[Team Management]]></category>
		<category domain="http://resources.bnet.com/topic/financial+services.html"><![CDATA[Financial Services]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/aap.html"><![CDATA[AAP]]></category>
	</item>
	<item>
		<title><![CDATA[Dendreon's New Stock Offering Takes Advantage of Provenge Decision Uncertainty]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005737/dendreons-new-stock-offering-takes-advantage-of-provenge-decision-uncertainty/]]></link>
		<description><![CDATA[Dendreon DNDN is taking advantage of the period of uncertainty before the FDA renders a May 1, 2010, decision on its Provenge prostate cancer treatment by raising money from a new stock sale. Dendreon shares fell today after the company announced it would dilute its 115.94 million outstanding shares with...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 09 Dec 2009 09:34:27 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[Stock]]></category>
		<category domain="http://resources.bnet.com/topic/investor.html"><![CDATA[Investor]]></category>
		<category domain="http://resources.bnet.com/topic/dendreon.html"><![CDATA[Dendreon]]></category>
		<category domain="http://resources.bnet.com/topic/provenge.html"><![CDATA[Provenge]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Big Pharma's Facebook Fail]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005698/big-pharmas-facebook-fail/]]></link>
		<description><![CDATA[UCB Pharma (UCB.BR) has an Epilepsy Facebook page that doesn't mention it's published by UCB. And AstraZeneca AZN has a page for Nexium that does not let visitors post messages on its Wall. Adweek revisits the long-established phenom of drug companies not liking social media in case patients start telling...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 07 Dec 2009 12:57:25 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/web.html"><![CDATA[Web]]></category>
		<category domain="http://resources.bnet.com/topic/facebook.html"><![CDATA[Facebook]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/social+media.html"><![CDATA[Social Media]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/web+2.0.html"><![CDATA[Web 2.0]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/internet.html"><![CDATA[Internet]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Shire's Daytrana Patch Recall Is 8th So Far: Time to Pull the Plug?]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005680/shires-daytrana-patch-recall-is-8th-so-far-time-to-pull-the-plug/]]></link>
		<description><![CDATA[Shire SHPGY has voluntarily recalled the Daytrana ADHD patch citing problems with patients removing the liner on the back. It is not a safety issue, the company says. Daytrana is for children with ADHD; it is the only patch product to treat the condition. "Sudden death" is one of the...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 07 Dec 2009 08:02:01 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/recall.html"><![CDATA[Recall]]></category>
		<category domain="http://resources.bnet.com/topic/johnson+%2526+johnson.html"><![CDATA[Johnson & Johnson]]></category>
		<category domain="http://resources.bnet.com/topic/patch+management.html"><![CDATA[Patch Management]]></category>
		<category domain="http://resources.bnet.com/topic/shire.html"><![CDATA[Shire]]></category>
		<category domain="http://resources.bnet.com/topic/daytrana+adhd.html"><![CDATA[Daytrana ADHD]]></category>
		<category domain="http://resources.bnet.com/topic/noven.html"><![CDATA[Noven]]></category>
		<category domain="http://resources.bnet.com/topic/wilco.html"><![CDATA[Wilco]]></category>
		<category domain="http://resources.bnet.com/topic/patches.html"><![CDATA[Patches]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
		<category domain="tickers">JNJ</category>
	</item>
	<item>
		<title><![CDATA[FDA Has Only 2 Inspectors Watching Drug Factories in China]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005667/fda-has-only-2-inspectors-watching-drug-factories-in-china/]]></link>
		<description><![CDATA[The FDA has only two inspectors for medical products in China, the country to which much of the drug industry is moving its manufacturing and R&D facilities. The FDA confirmed the number at the request of BNET, following reports that Pfizer PFE, AstraZeneca AZN, Eli Lilly LLY and Novartis NVS...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 04 Dec 2009 12:14:24 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Comcast-NBCU: How Comcast Is Pitching The Deal To DC]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fpaidcontent.org%2Farticle%2F419-comcast-nbcu-how-comcast-is-pitching-the-deal-to-dc%2F&siteid=23&tag=contentnext]]></link>
		<description><![CDATA[ The effort to win regulatory approval for Comcast&#8217;s acquisition of 51 percent of NBCU kicked into gear with the deal&#8217;s announcement, starting with a five-page memo from Comcast (NSDQ: CMCSA) EVP David Cohen laying out the &#8220;public interest commitments&#8221; the company will make to the Federal Communications Commission. That...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 03 Dec 2009 12:10:15 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/comcast+corp..html"><![CDATA[Comcast Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/labor+relations.html"><![CDATA[Labor Relations]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/mergers+%2526+acquisitions.html"><![CDATA[Mergers & Acquisitions]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/legal.html"><![CDATA[Legal]]></category>
		<category domain="http://resources.bnet.com/topic/regulatory.html"><![CDATA[Regulatory]]></category>
		<category domain="http://resources.bnet.com/topic/fcc.html"><![CDATA[FCC]]></category>
		<category domain="http://resources.bnet.com/topic/companies.html"><![CDATA[Companies]]></category>
		<category domain="http://resources.bnet.com/topic/comcast.html"><![CDATA[Comcast]]></category>
		<category domain="http://resources.bnet.com/topic/nbc+universal.html"><![CDATA[NBC Universal]]></category>
		<category domain="http://resources.bnet.com/topic/staci+d.+kramer.html"><![CDATA[Staci D. Kramer]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CMCSA</category>
		<category domain="tickers">CMCSA</category>
	</item>
	<item>
		<title><![CDATA[Can Novartis Win Race to Launch First Oral Drug for MS?]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005592/can-novartis-win-race-to-launch-first-ms-oral-drug/]]></link>
		<description><![CDATA[Novartis AG is jockeying with German drug maker Merck KgaA to deliver the first disease-modifying treatment for relapsing forms of multiple sclerosis that can be taken orally, rather than by infusion or injection. Fingolimod could finally move ahead in the race to market, as the FDA rejected Merck's new drug...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 03 Dec 2009 10:25:11 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/microsoft+corp..html"><![CDATA[Microsoft Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/tablets.html"><![CDATA[Tablets]]></category>
		<category domain="http://resources.bnet.com/topic/notebooks.html"><![CDATA[Notebooks]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/hardware.html"><![CDATA[Hardware]]></category>
		<category domain="http://resources.bnet.com/topic/notebooks+%2526+tablets.html"><![CDATA[Notebooks & Tablets]]></category>
		<category domain="http://resources.bnet.com/topic/david+phillips.html"><![CDATA[David Phillips]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MSFT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">MRK,MSFT,NVS</category>
	</item>
	<item>
		<title><![CDATA[Arrest Imminent in Florida Ponzi Case: Report]]></title>
		<link><![CDATA[http://www.bnet.com/2407-13071_23-369066.html]]></link>
		<description><![CDATA[MIAMI (<a href="http://resources.bnet.com/index.php?source=Reuters">Reuters</a>) - A disbarred Florida lawyer accused by the FBI of running a $1 billion investment scam is expected to be arrested Tuesday on racketeering conspiracy charges, The Miami Herald reported.Scott Rothstein, who fled to Morocco in late October but returned to Florida in early November, is expected to...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Tue, 01 Dec 2009 03:30:46 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fort+lauderdale.html"><![CDATA[Fort Lauderdale]]></category>
		<category domain="http://resources.bnet.com/topic/investor.html"><![CDATA[Investor]]></category>
		<category domain="http://resources.bnet.com/topic/florida.html"><![CDATA[Florida]]></category>
		<category domain="http://resources.bnet.com/topic/conspiracy+law.html"><![CDATA[Conspiracy Law]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/fbi.html"><![CDATA[FBI]]></category>
		<category domain="http://resources.bnet.com/topic/rothstein.html"><![CDATA[Rothstein]]></category>
	</item>
	<item>
		<title><![CDATA[FDA Offers Pfizer's HIV Drug Selzentry New Life -- For All the Good It Will Do]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005550/fda-offers-pfizers-hiv-drug-selzentry-new-life-for-all-the-good-it-will-do/]]></link>
		<description><![CDATA[The FDA approved Pfizer's anti-HIV drug Selzentry for expanded use in combination with other antiretroviral agents for treatment-naÃ¯ve patients who are infected with only CCR5-tropic HIV-1. Contrary to company expectations, perceived limitations of this entry inhibitor could stall efforts to facilitate usage beyond salvage therapy. by David Phillips]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 30 Nov 2009 10:57:52 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/hiv+virus.html"><![CDATA[HIV Virus]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/david+phillips.html"><![CDATA[David Phillips]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Can Novartis JAK Up Incyte's Profitability?]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005537/can-novartis-jak-up-incytes-profitability/]]></link>
		<description><![CDATA[Paul Friedman, chief executive of Incyte, believes that a newly-inked collaborative and licensing deal with Novartis for INCB18424, an oral JAK1/JAK2 inhibitor entering late-stage development for the blood disorder myelofibrosis, could drive the company to first-time profitability. Although early clinical evidence suggests that regulating cell signaling through this cytokine pathway...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 30 Nov 2009 10:52:09 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/david+phillips.html"><![CDATA[David Phillips]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[AstraZeneca Moves Drug Production to China, Begging Safety Questions for FDA]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005527/astrazeneca-to-move-drug-production-to-china-trend-begs-safety-questions-for-fda/]]></link>
		<description><![CDATA[AstraZeneca AZN will move all its drug production to China. The move is part of a trend: Drug companies with massive Western operations are shutting them down and moving them to China. The unanswered question is, how will the FDA monitor production of drugs destined for the U.S. if all...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 27 Nov 2009 19:40:22 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/monitors+%2526+displays.html"><![CDATA[Monitors & Displays]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/hardware.html"><![CDATA[Hardware]]></category>
		<category domain="http://resources.bnet.com/topic/components.html"><![CDATA[Components]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[Federal Contracting Fraud Continues]]></title>
		<link><![CDATA[http://industry.bnet.com/government/10004266/federal-contracting-fraud-continues/]]></link>
		<description><![CDATA[The Federal Government has several set aside programs.  One is for companies owned by disabled veterans.  There have been issues with contracts going to companies who fraudulently claimed the status.  New legislation is being developed to address this issue. by Matthew Potter]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 27 Nov 2009 04:00:51 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/issue.html"><![CDATA[Issue]]></category>
		<category domain="http://resources.bnet.com/topic/fraud.html"><![CDATA[Fraud]]></category>
		<category domain="http://resources.bnet.com/topic/contracting+fraud.html"><![CDATA[Contracting Fraud]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/litigation.html"><![CDATA[Litigation]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/matthew+potter.html"><![CDATA[Matthew Potter]]></category>
	</item>
	<item>
		<title><![CDATA[Viagra Now Available Intravenously]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005465/viagra-now-available-intravenously/]]></link>
		<description><![CDATA[Well, not quite. The FDA appoved Pfizer PFE's pulmonary arterial hypertension drug Revatio as an injection in cases where the patient is unable to swallow the tablets. Of course, Revatio sildenafil is the same drug as Viagra. It just has a different name and a different set of indications and...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 23 Nov 2009 06:46:09 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/tablets.html"><![CDATA[Tablets]]></category>
		<category domain="http://resources.bnet.com/topic/notebooks.html"><![CDATA[Notebooks]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/hardware.html"><![CDATA[Hardware]]></category>
		<category domain="http://resources.bnet.com/topic/notebooks+%2526+tablets.html"><![CDATA[Notebooks & Tablets]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Why Allergan and Medicis Should Embrace the "Botox Tax" in Senate Health Bill]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005435/why-allergan-and-medicis-should-embrace-the-botox-tax-in-senate-health-bill/]]></link>
		<description><![CDATA[The idea that Botox is a civil rights issue is ludicrous -- and yet that is the line being pushed by Allergan AGN in its fight against the 5 percent "Botox tax" proposed in the Senate healthcare reform bill. Instead, Allergan and its rival, Medicis MRX, should embrace this new...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 20 Nov 2009 12:21:25 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/allergan+inc..html"><![CDATA[Allergan Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+senate.html"><![CDATA[U.S. Senate]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare+reform.html"><![CDATA[Healthcare Reform]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/taxes.html"><![CDATA[Taxes]]></category>
		<category domain="http://resources.bnet.com/topic/free+trade.html"><![CDATA[Free Trade]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/financial+planning.html"><![CDATA[Financial Planning]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
		<category domain="tickers">AGN</category>
	</item>
	<item>
		<title><![CDATA[Zicam Makers Strike Back]]></title>
		<link><![CDATA[http://moneywatch.bnet.com/saving-money/blog/devil-details/zicam-makers-strike-back/1056/]]></link>
		<description><![CDATA[The makers of Zicam cold remedies turned their battle with the Food and Drug Administration public this week, filing a 33-page letter with securities regulators that discloses details of its long-running dispute. Now Zicam's parent company, Matrixx Initiatives, is asking that the FDA provide information about why it banned the...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 20 Nov 2009 08:57:36 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/maker.html"><![CDATA[Maker]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/kathy+kristof.html"><![CDATA[Kathy Kristof]]></category>
	</item>
	<item>
		<title><![CDATA[FDA Delays Genzyme's Lumizyme, Manufacturing Problems Blamed]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005372/a-cure-for-genzymes-pompe-disease-treatment-ceo-termeers-ouster/]]></link>
		<description><![CDATA[Genzyme announced that the FDA is delaying final approval of the company's application to market Lumizyme alglucosidase alfa for the treatment of Pompe disease. Not unexpected, given FDA regulators had sent out a memo last Friday warning healthcare providers that enzyme replacement drugs made at the Allston Landing plant might...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 19 Nov 2009 07:56:16 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/genzyme+corp..html"><![CDATA[Genzyme Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/david+phillips.html"><![CDATA[David Phillips]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GENZ</category>
		<category domain="tickers">GENZ</category>
	</item>
	<item>
		<title><![CDATA[FDA Accused of Caving to Industry in Oyster Row]]></title>
		<link><![CDATA[http://industry.bnet.com/food/10001119/fda-accused-of-caving-to-industry-in-oyster-row/]]></link>
		<description><![CDATA[Under President Barack Obama, the Food and Drug Administration has showed some backbone for the first time in years. But now it's backtracking on the issue of raw oysters from the Gulf Coast, thrilling industry but disappointing health advocates.    The FDA had announced new rules, effective 2011,...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 17 Nov 2009 10:00:32 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/industry.html"><![CDATA[Industry]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/katherine+glover.html"><![CDATA[Katherine Glover]]></category>
	</item>
</channel>
</rss>
